Elisabeth Kogan is the founder of Syremis Therapeutics. Syremis Therapeutics has raised $165M in total funding. Latest round: Series A.
Elisabeth Kogan is the Co-founder and CEO of Syremis Therapeutics, a clinical-stage biopharmaceutical company focused on novel medicines for mental health and neuropsychiatric conditions. She co-founded the company in 2025 and announced its launch with a $165 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library